Culture

Research reveals unexpected insights into early dinosaur's brain, eating habits and agility

image: Braincase and endocast of Thecodontosaurus antiquus. From CT scans of the braincase fossil, 3-D models of the braincase and the endocast were generated and studied.

Image: 
Created by Antonio Ballell with BioRender.com, Thecodontosaurus silhouette from PhyloPic.org.

A pioneering reconstruction of the brain belonging to one of the earliest dinosaurs to roam the Earth has shed new light on its possible diet and ability to move fast.

Research, led by the University of Bristol, used advanced imaging and 3-D modelling techniques to digitally rebuild the brain of Thecodontosaurus, better known as the Bristol dinosaur due to its origins in the UK city. The palaeontologists found Thecodontosaurus may have eaten meat, unlike its giant long-necked later relatives including Diplodocus and Brontosaurus, which only fed on plants.

Antonio Ballell, lead author of the study published today in Zoological Journal of the Linnean Society, said: "Our analysis of Thecodontosaurus' brain uncovered many fascinating features, some of which were quite surprising. Whereas its later relatives moved around ponderously on all fours, our findings suggest this species may have walked on two legs and been occasionally carnivorous."

Thecodontosaurus lived in the late Triassic age some 205 million years ago and was the size of a large dog. Although its fossils were discovered in the 1800s, many of which are carefully preserved at the University of Bristol, scientists have only very recently been able to deploy imaging software to extract new information without destroying them. 3-D models were generated from CT scans by digitally extracting the bone from the rock, identifying anatomical details about its brain and inner ear previously unseen in the fossil.

"Even though the actual brain is long gone, the software allows us to recreate brain and inner ear shape via the dimensions of the cavities left behind. The braincase of Thecodontosaurus is beautifully preserved so we compared it to other dinosaurs, identifying common features and some that are specific to Thecodontosaurus," Antonio said. "Its brain cast even showed the detail of the floccular lobes, located at the back of the brain, which are important for balance. Their large size indicate it was bipedal. This structure is also associated with the control of balance and eye and neck movements, suggesting Thecodontosaurus was relatively agile and could keep a stable gaze while moving fast."

Although Thecodontosaurus is known for being relatively small and agile, its diet has been debated.

Antonio, a PhD student at the University of Bristol's School of Earth Sciences, said: "Our analysis showed parts of the brain associated with keeping the head stable and eyes and gaze steady during movement were well-developed. This could also mean Thecodontosaurus could occasionally catch prey, although its tooth morphology suggests plants were the main component of its diet. It's possible it adopted omnivorous habits."

The researchers were also able to reconstruct the inner ears, allowing them estimate how well it could hear compared to other dinosaurs. Its hearing frequency was relatively high, pointing towards some sort of social complexity - an ability to recognise varied squeaks and honks from different animals.

Professor Mike Benton, study co-author, said: "It's great to see how new technologies are allowing us to find out even more about how this little dinosaur lived more than 200 million years ago.

"We began working on Thecodontosaurus in 1990, and it is the emblem of the Bristol Dinosaur Project, an educational outreach scheme where students go to speak about science in local schools. We're very fortunate to have so many well-preserved fossils of such an important dinosaur here in Bristol. This has helped us understand many aspects of the biology of Thecodontosaurus, but there are still many questions about this species yet to be explored."

Credit: 
University of Bristol

No association between COVID-19 and Guillain-Barré syndrome

Neuroscientists at UCL have found no significant association between COVID-19 and the potentially paralysing and sometimes fatal neurological condition Guillain-Barré syndrome.

Researchers say the findings, published in the journal Brain*, along with a linked scientific commentary** by UCL and other international experts, should provide the public with reassurance, as the UK's national coronavirus vaccination programme is rolled out.

Guillain-Barré syndrome (GBS) is a rare but serious autoimmune condition that attacks the peripheral nervous system, typically affecting the feet, hands and limbs, causing numbness, weakness and pain. While its exact cause is unknown, GBS often occurs after a gastroenteritis infection called Camplylobacter, with the immune system mistakenly attacking nerves rather than germs.

GBS is usually reversible, however in severe cases it can cause prolonged paralysis involving breathing muscles, require ventilator support and sometimes leave permanent neurological deficits. Early recognition by expert neurologists is key to proper treatment.

Historical context of virus- and vaccine-associated GBS

More cases of GBS were associated with the Zika virus outbreaks in Latin America (2016 and 2020) than expected by chance alone; and concerns have been raised in GBS research reports that a similar link may potentially exist between COVID-19 infection and GBS too.

Researchers also say fears of a global rise in GBS following mass vaccination may persist due to a historic small increase in GBS associated with the 1976 swine flu vaccination campaign in the USA. This vaccination campaign was halted because the risk of developing GBS was statistically increased from background, although subsequent statistical analysis found the risk of a link to be lower than initially thought. In every flu vaccination campaign since, the risk of GBS as a result of flu vaccination is estimated to be about one per million vaccination doses.

This study

In this epidemiological and cohort study, UCL researchers sought to investigate any causative association between COVID-19 infection and GBS.

The team assessed the number of GBS treatments reported to the NHS England National Immunoglobulin Database between 2016 and 2019. This was compared to the number of cases reported during the COVID-19 pandemic in the first half of 2020.

The annual incidence of GBS treated in UK hospitals between 2016 and 2019 was 1.65-1.88 per 100,000 individuals. Incidences of GBS fell 40-50% between March and May 2020 when compared to the same months of 2016-2019. This new finding contradicts that of other smaller and less extensive international studies.

First author, Dr Stephen Keddie (UCL Queen Square Institute of Neurology) said: "The possibility of SARS-CoV-2 driving a global spike in GBS has been eagerly monitored with a number of published small case series already asserting a causal link. However, a surge in GBS cases after the SARS-CoV-2 pandemic has not been detected as happened in the Zika virus pandemic.

"Our epidemiological study shows there was no increased incidence in GBS during the first wave of COVID-19; rather, there was a decrease and therefore no causal link of COVID-19 to GBS can be made."

Separately in this study the research team also tried to establish if there was any genetic or protein structure in SARS-CoV-2, the virus that causes COVID-19, which could trigger an immune response causing GBS. Unlike Camplylobacter, which contains human-like antigens causing an autoimmune response, no credible link was found with SARS-CoV-2.

Dr Keddie added: "Most COVID-19 vaccinations are based on the SARS-CoV-2 spike protein, which drives a complex immune response creating antibodies to fight infection.

"Our analysis shows SARS-CoV-2 contains no additional immunogenic material known or proven to drive GBS. Concerns that COVID vaccination might cause GBS in any significant numbers are therefore almost certainly unfounded."

Around 1,500 cases of GBS occur in the UK each year (two per 100,000 population). History suggests, researchers say, that mass vaccination might be blamed for cases of GBS when occurring by chance, particularly with billions of people expected to be immunised globally.

Corresponding author, Professor Michael Lunn (UCL Queen Square Institute of Neurology) said: "When we immunise the population against COVID-19, GBS (and other neurological illnesses) will occur, by chance alone, in the weeks after immunisation, the window for a normal response to the vaccine.

"These cases may cause concern in patients, politicians, and regulators and stoke anti-vaccination concerns, even though it is likely that most, if not all of the cases, will be associated with vaccination by chance alone.

"Such a severe illness may result in suspension or withdrawal of vaccination as a 'knee jerk' safety reaction but this must not happen unless there is a statistically demonstrated link through careful monitoring that is proven. We must accept small risks with any vaccination programme on this scale, and these are far lower than the risk from COVID infection."

Credit: 
University College London

Unexpectedly, data show that anaesthetists and intensive care doctors are at lower risk of SARS-CoV-2 infection compared with other medical staff

Following the first recorded death of an anaesthetist from COVID-19 in the UK in November 2020, a review of available data published in Anaesthesia (a journal of the Association of Anaesthetists) shows that unexpectedly, despite their perceived increased exposure to COVID-19 patients and high-risk procedures, anaesthetists and intensive care doctors appear to be at lower risk of being infected with SARS-CoV-2 and developing COVID-19.

The analysis was carried out by Professor Tim Cook, Consultant in Anaesthesia and Intensive Care Medicine, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK, and School of Medicine, University of Bristol, UK, and Dr Simon Lenanne, General Practitioner, Ross-on-Wye, Herefordshire, UK. The authors undertook the review following the death on November 12, 2020, of anaesthetist Dr Krishnan Subramanian, who was aged 46 years and worked at the Royal Derby Hospital, UK.

"This very sad event is a moment for pause and reflection. Every death is a tragedy, and our first thoughts should be with Dr Subramanian's family, friends and colleagues," say the authors.

Reviewing numerous studies, the authors say that overall, healthcare workers in patient-facing roles are at two- to four-fold increased risk of infection and harm from COVID-19. Household members of healthcare staff are also at increased risk. However, it remains uncertain whether working in a patient-facing healthcare role significantly increases the risk of death from COVID-19.

"Three separate studies from Oxford, Leicester and Birmingham and including more than 20,000 healthcare staff indicate that those working in anaesthesia and intensive care had less than half the risk of infection than physicians dealing with COVID-19 patients on the wards. These studies also found significantly higher rates of infection in both front-line nurses and housekeeping staff compared to anaesthetists and intensivists," say the authors. "And in a study of Scottish of hospital admission of healthcare workers, working in ICU was again associated with approximately half the risk of working in 'front door' roles. Even household contacts of 'front door' healthcare workers had a higher risk of hospital admission than those working in ICU."

The authors also conducted an analysis to explore whether deaths of anaesthetists were lower than expected amongst the general population and amongst healthcare workers. Using data from The Royal College of Anaesthetists census, NHS Digital, the Office of National Statistics, and their own database of healthcare worker deaths the authors compared the expected and observed number of deaths amongst UK anaesthetists/ intensivists with various comparator groups.

Overall deaths amongst anaesthetists and intensivists were disproportionately low - ranging between less than a half to a quarter of expected deaths based on the numbers working in this speciality. The number of deaths expected among anaesthetists, based on representation of anaesthetists among doctors, and COVID-19 related deaths among the general population would be several times higher than the single death recorded so far (3 or 4 in total).

The authors explain: "This analysis indicates that, irrespective of the comparator group used, deaths among anaesthetists and intensivists are notably lower than expected and certainly not high, as some would have predicted."

The authors offer several possible explanations for the lower risk observed. These include better personal protective equipment or better use of it, working in well-ventilated environments and the possibilities that both the patients who are admitted to ICU are less infectious than those on the wards, and that the high risk procedures such as establishing a patient on a ventilator (including intubation) are not as high risk as has been assumed.

The authors say: "This analysis highlights both the relative safety of anaesthetists and intensivists from occupational harm from SARS-CoV-2 and the increased risks for others working on the wards, both in clinical and non-clinical roles."

They conclude: "It is our opinion that those working in anaesthesia and critical care should continue with current practices to maintain their own safety and that of their working environment. A more challenging question is whether some of the procedures that appear to keep anaesthetists and intensivists safe such as high level protective respirators should be extended to general practice and the wards where other healthcare workers are more at risk."

Dr Mike Nathanson, President of the Association of Anaesthetists, said: "The whole profession was saddened to hear of the tragic death of Dr Krishnan Subramanian. It is reassuring to see that, to date, we have lost no further anaesthestists or intensivists to COVID-19 despite their involvement on the front line of battling this pandemic. The death of each healthcare worker has been in our minds, however. This analysis reminds us of the risks, and of factors that may explain why anaesthetists and intensivists appear to have so far largely escaped the worst of this illness. We are not complacent, and we will continue to work for the wellbeing of the anaesthetists and intensivists we represent."

Credit: 
AAGBI

Carrots are healthy, but active enzyme unlocks full benefits

image: (From left): Doctoral students Ivan Pinos and Johana Coronel, and Assistant Professor Jaume Amengual, Department of Food Science and Human Nutrition at University of Illinois, with the latest issue of the Journal of Lipid Research, featuring their research on the cover.

Image: 
College of ACES.

URBANA, Ill. - Carrots are a good source of beta-carotene, which is a precursor of vitamin A. But to get the full health benefits of this superfood, you need an active enzyme to produce this vitamin.

Beta-carotene is the bioactive compound that gives carrots their orange color. Studies with humans and mice show the conversion of beta-carotene to vitamin A reduces "bad" cholesterol in the blood. Thus, beta-carotene can help protect against atherosclerosis development, which leads to the accumulation of fats and cholesterol in our arteries. Atherosclerosis cardiovascular disease is the primary cause of death worldwide, says Jaume Amengual, assistant professor of personalized nutrition in the Department of Food Science and Human Nutrition at University of Illinois.

Amengual and his colleagues conducted two studies to further understand the effects of beta-carotene on cardiovascular health. They confirmed its importance, but identified a critical step in the process.

Beta-carotene converts to vitamin A with the help of an enzyme called beta-carotene oxygenase 1 (BCO1). A genetic variation determines if you have a more or less active version of BCO1. People with a less active enzyme could need other sources for vitamin A in their diet, Amengual says.

The first study, published in the Journal of Nutrition, analyzed blood and DNA samples from 767 healthy young adults aged 18 to 25. As expected the researchers found a correlation between BCO1 activity and bad cholesterol level.

"People who had a genetic variant associated with making the enzyme BCO1 more active had lower cholesterol in their blood. That was our first observation," Amengual notes.

To follow up on these findings, Amengual and his colleagues conducted a second study, published in the Journal of Lipid Research, using mice.

"In the human study, we saw that cholesterol was higher in people who do not produce much vitamin A. To know if that observation has an effect in the long run, we would have to wait 70 years to see if they develop cardiovascular. In real life, that is not doable. That's why we use animals for certain studies, so we can speed up the process," he explains.

"The main findings of the mice study reproduce what we found in humans. We saw that when we give beta-carotene to mice, they have lower cholesterol levels. These mice develop smaller atherosclerosis lesions, or plaques, in their arteries. This means that mice fed beta-carotene are more protected against atherosclerosis than those fed a diet without this bioactive compound," Amengual states.

In the second study, the researchers also investigated the biochemical pathways of these processes, determining where in the body the effect occurs.

"We narrow it down to the liver as the organ in charge of producing and secreting lipoproteins to the bloodstream, including those lipoproteins known as bad cholesterol. We observed that in mice with high levels of vitamin A, the secretion of lipids into the bloodstream slows down," Amengual notes.

Understanding how the BCO1 enzyme relates to cholesterol has important implications. Typically, high beta-carotene levels in the blood are associated with health benefits. But it could also be a sign of a less active BCO1 enzyme that is not converting the beta-carotene we eat into vitamin A.

Up to 50% of the population have the less-active variant of the enzyme, Amengual notes. That means their body is slower at producing vitamin A from a plant source, and they could need to get this nutrient directly from an animal source such as milk, or cheese, for example.

Credit: 
University of Illinois College of Agricultural, Consumer and Environmental Sciences

Sounds, smells could sway our self-image

image: A lemony scent and light sounds could change the way you feel about yourself. Previously, researchers have shown that visual and tactile stimulation can change a person's perception of their own body weight. Research being presented by Giada Brianza at the 179th ASA Meeting, has found our hearing and sense of smell can also change how we feel about our self-image, which could help improve healthy behaviors.

Image: 
Giada Brianza

MELVILLE, N.Y., December 11, 2020 -- A lemony scent and light sounds could change the way you feel about yourself.

Previously, researchers have shown that visual and tactile stimulation can change a person's perception of their own body weight. Research being presented by Giada Brianza, of the University of Sussex, has found our hearing and sense of smell can also change how we feel about our self-image, which could help improve healthy behaviors.

The presentation, "Understanding the impact of sound and smell on body image perception," will be a part of the 179th Meeting of the Acoustical Society of America. This session will be presented on Dec. 11 at 12:20 p.m. Eastern U.S. The meeting will be held virtually Dec. 7-10.

To see if sounds could change body image perceptions, the researchers used headphones to alter in real time how patients heard their own footsteps. Heavier bodies produce lower frequency footsteps than lighter bodies, so the researchers thought that changing the sound could alter how a person perceives their own image.

When the researchers played higher-pitch footsteps that sounded like stilettos, the test subjects were walking faster compared with when they heard lower pitch sounds, like the sound boots make.

The researchers also tested how scents could change one's perceived body image. They found exposure to lemon-scented essential oils in combination with high-pitched sounds during the experiments made participants feel lighter than vanilla scents.

These first results in sound-scent body image association are still being studied, but already the power of audio on body image has promising applications. Since negative body image can lead to increased risks for eating disorders, isolation, and emotional distress, finding ways to manipulate self-image could enhance health through promoting better self-image.

The researchers believe that multisensory stimuli -- sound and smell, in particular -- should play a greater role in treating body image diseases, like eating disorders.

Credit: 
Acoustical Society of America

New tool for watching and controlling neural activity

A new molecular probe from Stanford University could help reveal how our brains think and remember. This tool, called Fast Light and Calcium-Regulated Expression or FLiCRE (pronounced "flicker"), can be sent inside any cell to perform a variety of research tasks, including tagging, recording and controlling cellular functions.

"This work gets at a central goal of neuroscience: How do you find the system of neurons that underlie a thought or cognitive process? Neuroscientists have been wanting this type of tool for a long time," said Alice Ting, professor of genetics in the Stanford School of Medicine and of biology in the School of Humanities and sciences, whose team co-led this work with the lab of Stanford psychiatrist and bioengineer, Karl Deisseroth.

In proof-of-concept experiments, detailed in a paper published Dec. 11 in Cell, the researchers used FLiCRE to take a snapshot of neural activity associated with avoidance behavior in mice. By coupling the FLiCRE snapshot with RNA sequencing, they discovered that these activated neurons primarily belonged to a single cell type, which was inaccessible using genetic tools alone. They then used FLiCRE in combination with an opsin - a protein for controlling neural activity with light developed by Deisseroth - to reactivate those same neurons a day later, which led the mice to avoid entering a certain room. The brain region the researchers studied, called the nucleus accumbens, is thought to play an important role in human psychiatric diseases, including depression.

Modular molecular technology

FLiCRE is made up of two chains of molecular components that respond to the presence of blue light and calcium. This light sensitivity allows the researchers to precisely control the timing of their experiments, and calcium is an almost-universal indicator of cell activity. To get FLiCRE inside a cell, the researchers package it, in two parts, within a harmless virus. One part of FLiCRE attaches to the cell membrane and contains a protein that can enter the cell's nucleus and drive expression of whatever gene the researchers have selected. The other part of FLiCRE is responsible for freeing the protein under certain specific conditions, namely if the concentration of calcium is high and the cell is bathed in blue light.

Whereas existing tagging techniques require hours to activate, the FLiCRE tagging process takes just minutes. The researchers also designed FLiCRE so that they can use standard genetic sequencing to find the cells in which FLiCRE activated. This allows them to study tens of thousands of cells at once, while other techniques tend to require the analysis of multiple microscopic images that each contain hundreds of cells.

In one series of experiments, the researchers injected FLiCRE into cells in the nucleus accumbens and used an opsin to activate a neural pathway associated with avoidance behavior in the mice. Once the calcium in FLiCRE-containing cells spiked - the cellular indication that the mouse is avoiding something - the cells glowed a permanent red that was visible through a microscope. The researchers also sequenced the RNA of the cells to see which ones contained the fluorescent protein, producing a cell-by-cell record of neural activity.

"One goal was to map how brain regions are connected to each other in living animals, which is a really hard problem," said Christina Kim, a postdoctoral scholar in genetics at Stanford and co-lead author of the paper. "The beauty of FLiCRE is that we can pulse and activate neurons in one region and then record all of the connected downstream neurons. It is a really cool way to look at long-range brain activity connections."

In the next experiments, the researchers used the cellular activity map from the first experiments. They also adjusted FLiCRE so that the protein expressed the opsin protein, which can be controlled by orange light to alter neuronal activity. After activating FLiCRE in the cells, the researchers sent orange light through the fiber optic implant whenever the mice would enter a certain room. In response, the mice steered clear of that room, indicating that FLiCRE had indeed located cells in the brain that drive avoidant behavior.

A dream project

The development and testing of FLiCRE combined chemistry, genetics, biology and neuroscience, and many specialties within those disciplines. As a result, the tool has a wide range of possible applications, including in cells outside the brain, the researchers say.

"I moved to Stanford in 2016 with the hope of being able to carry out extremely interdisciplinary and collaborative projects such as this," said Ting. "This project has been one of the most rewarding aspects of my move to Stanford - seeing something this challenging and ambitious actually work out."

The researchers are now working on additional versions of FLiCRE, with a goal of streamlining the process. They are hoping to simplify its structure and also make it capable of working with other biochemical events, such as protein interactions or neurotransmitter release.

Credit: 
Stanford University

Genes could be key to new COVID-19 treatments, study finds

Potential treatments for Covid-19 have been identified after the discovery of five genes associated with the most severe form of the disease.

Genetic evidence is second only to clinical trials as a way to tell which treatments will be effective in a disease. Existing drugs that target the actions of the genes reveal which drugs should be repurposed to treat Covid-19 in clinical trials, experts say.

Genes involved in two molecular processes - antiviral immunity and lung inflammation - were pinpointed. The breakthrough will help doctors understand how Covid-19 damages lungs at a molecular level.

Researchers from the University of Edinburgh made the discovery by studying the DNA of 2,700 patients in 208 intensive care units (ICUs) in the UK.

Researchers from the GenOMICC consortium - a global collaboration to study genetics in critical illness - compared the genetic information of Covid-19 patients in ICU with samples provided by healthy volunteers from other studies, such as UK Biobank, Generation Scotland and 100,000 Genomes.

The team found key differences in five genes of the ICU patients compared with samples provided by healthy volunteers. The genes - IFNAR2, TYK2, OAS1, DPP9 and CCR2 - partially explain why some people become desperately sick with Covid-19, while others are not affected.

Having highlighted the genes, the team were then able to predict the effect of drug treatments on patients, because some genetic variants respond in a similar way to particular drugs.

For example, they showed that a reduction in the activity of the TYK2 gene protects against Covid-19. A class of anti-inflammatory drugs called JAK inhibitors, which includes the drug baricitinib, produces this effect.

They also discovered that a boost in the activity of the gene INFAR2 is also likely to create protection, because it is likely to mimic the effect of treatment with interferon - proteins released by cells of the immune system to defend against viruses. However, experts caution that to be effective, patients might need the treatment early in disease.

Based on the findings published in Nature, the researchers say that clinical trials should focus on drugs that target these specific antiviral and anti-inflammatory pathways.

Dr Kenneth Baillie, the project's chief investigator and Academic Consultant in Critical Care Medicine and Senior Research Fellow at University of Edinburgh's Roslin Institute, said: "This is a stunning realisation of the promise of human genetics to help understand critical illness. Just like in sepsis and influenza, in Covid-19, damage to the lungs is caused by our own immune system, rather than the virus itself. Our genetic results provide a roadmap through the complexity of immune signals, showing the route to key drug targets.

"Our results immediately highlight which drugs should be at the top of the list for clinical testing. We can only test a few drugs at a time, so making the right choices will save thousands of lives.

"This work is only possible because of the generous contribution of the patients themselves and their families, research teams in NHS hospitals across the country, and the generous funding we've received from the public and organisations."

GenOMICC (Genetics of Susceptibility and Mortality in Critical Care) started in 2015 as an open, global consortium of intensive care clinicians dedicated to understanding genetic factors that influence outcomes in intensive care from diseases such as SARS, influenza and sepsis. Throughout 2020 it has been focused on Covid-19 research in partnership with Genomics England.

Credit: 
University of Edinburgh

Polarization increases with economic decline, becoming cripplingly contagious

PRINCETON, N.J.--The rise of populist movements is changing political systems around the world. As support for these "anti-elite" movements intensifies, many are scrambling to understand whether economic decline and intensifying inter-group conflict are playing a role.

A model developed by a team of researchers -- including Nolan McCarty of Princeton University -- shows how group polarization, rising inequality, and economic decline may be strongly connected.

The model develops a theory that group polarization tends to soar in times of economic duress and rising inequality. Yet, even after financial conditions improve, these divisions may remain deeply rooted.

This is why strengthened social safety nets are needed to help minimize conflict across social, ethnic, and racial groups, the researchers argue in Science Advances.

"Times arise when national unity is needed, like we're seeing now with Covid-19, but we shouldn't wait for a public health crisis or war to bring people together. Policymakers and those in government should act now by investing in and protecting social safety nets that can prevent widening social and political divisions," said McCarty, who is the Susan Dod Brown Professor of Politics and Public Affairs at the Princeton School of Public and International Affairs.

McCarty worked on the model with Alexander Stewart of the University of Houston and Joanna Bryson of the Hertie School in Berlin, Germany. Using models of cultural evolution and evolutionary game theory, the team designed their model to examine people's willingness to interact with people outside their own social group.

The model is based on a few assumptions -- the first being that an individual's economic success is tied to interactions with others and the performance of the underlying economy. They also assume that people tend to mimic the behavior of seemingly "successful" people so that social behaviors can spread through the public.

Lastly they assume that interactions within social in-group behavior is generally less risky with lower rewards while interactions with out-group members are more risky, but entail greater upside. This means that when economic conditions become more challenging, people will tend to prefer the safe bet of interacting with their own kind and avoid interactions with outsiders. As such behavior is mimicked, the interactions across groups declines precipitously.

The model may be helpful in explaining political trends seen around the world. First, the model supports theories arguing that economic shocks embolden those far-right movements predicated vilifying social out-groups. For example, the Great Depression and Global Financial Crisis both led to increased support for right-wing populists in a number of countries including the United States, and the United Kingdom.

When it comes to inequality, most models suggest that a significant wealth gap tends to empower those on the left, as they will seek income redistribution. The researchers' new model doesn't necessarily show such a shift, but instead a general move away from interactions across social identity groups. Since cross-group interactions are economically valuable, society gets poorer.

"Rather than continue the unproductive debate over whether 'economic anxiety' or group conflict is most responsible for our deeply divided politics, scholars should spend more effort considering the debilitating feedback between economics and identity," said McCarty.

Credit: 
Princeton School of Public and International Affairs

Fewer than 2 percent of OB-GYN doctors can prescribe life-saving opioid treatment

The number of obstetrician-gynecologists who are able to prescribe a lifesaving opioid addiction medicine called buprenorphine to their patients is woefully small, comprising less than two percent of the 31,000-plus doctors studied across the country, according to new analysis. This is especially concerning as the proportion of those expecting to give birth who are using prescription opioids has increased exponentially in the last several decades. The researchers' findings were published today in JAMA Network Open.

"There is room for OB-GYNs to curb the opioid epidemic by filling gaps we see in treatment of pregnant patients," said the study's lead author, Max Jordan Nguemeni Tiako, MS, a medical student at Yale University who worked on this research as a fellow at the Perelman School of Medicine of the University of Pennsylvania. "Many of those who are getting substance use care are also not getting any reproductive care at all, so there's also a potential bridge opportunity here, too."

Tiako joined with several researchers, including the study's senior author, Zachary Meisel, MD, director for the Center for Emergency Care Research and Policy, and Sindhu Srinivas, MD, vice chair of quality and safety for Obstetrics and Gynecology, to examine how many United States OB-GYNs have their X-waiver, a certification that allows them to prescribe opioid treatment medications like buprenorphine. A "partial-agonist," buprenorphine soothes the brain's cravings for opioids by partially activating opiate receptors, and binding to them tightly (more than most other opioids), decreasing the risk of fatal overdoses. On top of that, buprenorphine has been approved by the Food and Drug Administration (FDA) for use in those who are pregnant.

This is important, because numbers are showing significant increases in opioid use among those who are expecting to give birth. In the 20 years between 1992 and 2020, the rate of pregnant patients receiving substance use treatment for opioids went from 1 percent to 19, and fatal overdoses are becoming a leading cause of postpartum deaths. Additionally, from 2000 to 2014, the number of children born with an opioid withdrawal-like condition called neonatal abstinence syndrome (NAS) spiked, increasing from 1.2 per 1,000 to 8 per 1,000.

However, X-waivers aren't extremely common among doctors overall, not just among obstetrician-gynecologists. Obtaining an X-waiver requires training, which takes eight hours for physicians and 24 hours for nurse-practitioners and physician assistants. This could be taxing for physicians whose schedules are often totally full with their responsibilities to patients. Stigma - seeping in from society's attitudes toward substance use and even from some health care workers themselves - is likely also playing a role, Tiako said.

In an attempt to gauge how many obstetrician-gynecologists across the United States can prescribe life-saving opioid agonists - and where they are - the researchers compiled county- and state-level data on doctors who accept Medicaid. The data was pulled from September 2019.

A total of 31,311 doctors were identified. Of them, only 560 had their X-waiver, 1.8 percent.

"We didn't come in with great expectations because X-waiver rates aren't extremely high nationwide even in specialties where efforts have been made to improve them, such as Emergency Medicine," said Meisel. "But the numbers we saw are exceedingly low for the need that we know exists."

When dividing the numbers by area - divided into urban, suburban, and rural settings - differences were noted. OB-GYN doctors in suburban counties were 85 percent more likely to have their X-waiver than those in urban areas. Doctors in rural areas were more than twice as likely to have their X-waiver, but those figures were not found to be statistically significant and could be misleading.

"There are, overall, very few OBGYNs in entirely rural areas, in which case the need for buprenorphine is being primarily met by nurse practitioners and physician assistants," said Tiako. "We did not capture their numbers in this study, but we believe that the level of care through buprenorphine there is also likely not to be high."

Additionally, the study showed that OB-GYN doctors in areas where the rates of infants born with neonatal abstinence syndrome were highest, doctors were five times as likely to have their X-waiver compared to those in the areas with the lowest rates of the syndrome.

"We saw that the need isn't being matched anywhere, but it seems possible that the severity of the opioid epidemic might be driving greater rates in areas that need it," Tiako said. "That said, these results matched some prior studies that showed buprenorphine was more accessible to people living in suburban settings, who are mostly white, commercially ensured patients. When buprenorphine was rolled out, the pharmaceutical campaign targeted private practice physicians who likely had more time to do the X-waiver training. If you work in a FQHC (federally qualified health center), time is a much rarer commodity and it's less likely that you can commit to that."

Moving forward, Tiako said he and his fellow researchers have distributed a survey to reproductive health providers as well as substance use disorder providers to gauge their attitudes and practices toward patients with substance use disorders, and toward pregnant patients, respectively. He's looking forward to analyzing the responses.

"We're trying to identify the gap so that it can be closed," Tiako explained. "That could help us improve care all around, from substance use to reproductive care."

Credit: 
University of Pennsylvania School of Medicine

Scientists found out genes involved in a compound in lichens with antiviral activity

An international study led by researchers from the Faculty of Pharmacy at the Complutense University of Madrid has identified a series of biosynthetic genes involved in the production of usnic acid in lichen, a compound showing antiviral, antioxidant, neuroprotective, antibacterial and anticancer activity.

Not all lichens --composite organisms resulting from the symbiosis of fungi and green algae or cyanobacteria-- produce this compound, and this study, published in Genome Biology and Evolution, has revealed why there is a loss of specific biosynthetic genes in non-producing species.

"Identifying the genes involved in the biosynthesis of these compounds is essential for future studies that require their isolation and mass production; similarly, the genomic approach adopted in this study has helped us identify new biosynthetic genes (PKS) of as yet unknown compounds that may be of pharmacological interest", explained David Pizarro, the first author of the study and a researcher in the Department of Pharmacology, Pharmacognosy and Botany at the UCM.

To carry out this study, researchers sequenced the genomes of 40 lichen species that produce and do not produce usnic acid.

"The genomes were assembled, annotated and compared using bioinformatics tools and computational biology, and we also analysed the diversity of lichen compounds using chromatography", Pizarro added.

New family with unknown function

This study also identified and described a new family of biosynthetic genes (PKS) with an unknown function that may be specific to lichens.

"We identified numerous clusters of biosynthetic genes of unknown function, some of which are homologous to other genes involved in the biosynthesis of antibiotics and tox-ins, thus opening a novel avenue of research into new molecules in the pharmaceutical industry", reported Pradeep Divakar, another researcher in the Department of Pharma-cology, Pharmacognosy and Botany.

Lichens are of great ecological importance. They have been widely used as bio-indicators of air pollution and other factors because of their high sensitivity to environmental changes, they form the basis of the food chain in specialised ecosystems and they are also an important nest-building resource for birds due to the antibacterial and antifungal activity of their secondary compounds.

"Another important function of lichens relates to soil formation, since they can prevent soil erosion and help maintain moisture, facilitating the establishment of vascular plants", concluded Pizarro.

Credit: 
Universidad Complutense de Madrid

Gut microbiota plays a role in brain function and mood regulation

image: Gut microbiota plays a role in brain function and mood regulation

Image: 
(c) Institut Pasteur / Pascal Marseaud

Depression is a mental disorder that affects more than 264 million people of all ages worldwide. Understanding its mechanisms is vital for the development of effective therapeutic strategies. Scientists from the Institut Pasteur, Inserm and the CNRS recently conducted a study showing that an imbalance in the gut bacterial community can cause a reduction in some metabolites, resulting in depressive-like behaviors. These findings, which show that a healthy gut microbiota contributes to normal brain function, were published in Nature Communications on December 11, 2020.

The bacterial population in the gut, known as the gut microbiota, is the largest reservoir of bacteria in the body. Research has increasingly shown that the host and the gut microbiota are an excellent example of systems with mutually beneficial interactions. Recent observations also revealed a link between mood disorders and damage to the gut microbiota. This was demonstrated by a consortium of scientists from the Institut Pasteur, the CNRS and Inserm, who identified a correlation between the gut microbiota and the efficacy of fluoxetine, a molecule frequently used as an antidepressant. But some of the mechanisms governing depression, the leading cause of disability worldwide, remained unknown.

Using animal models, scientists recently discovered that a change to the gut microbiota brought about by chronic stress can lead to depressive-like behaviors, in particular by causing a reduction in lipid metabolites (small molecules resulting from metabolism) in the blood and the brain.

These lipid metabolites, known as endogenous cannabinoids (or endocannabinoids), coordinate a communication system in the body which is significantly hindered by the reduction in metabolites.
Gut microbiota plays a role in brain function and mood regulation

Endocannabinoids bind to receptors that are also the main target of THC, the most widely known active component of cannabis. The scientists discovered that an absence of endocannabinoids in the hippocampus, a key brain region involved in the formation of memories and emotions, resulted in depressive-like behaviors.

The scientists obtained these results by studying the microbiotas of healthy animals and animals with mood disorders. As Pierre-Marie Lledo, Head of the Perception and Memory Unit at the Institut Pasteur (CNRS/Institut Pasteur) and joint last author of the study, explains: "Surprisingly, simply transferring the microbiota from an animal with mood disorders to an animal in good health was enough to bring about biochemical changes and confer depressive-like behaviors in the latter."

The scientists identified some bacterial species that are significantly reduced in animals with mood disorders. They then demonstrated that an oral treatment with the same bacteria restored normal levels of lipid derivatives, thereby alleviating the depressive-like behaviors. These bacteria could therefore serve as an antidepressant. Such treatments are known as "psychobiotics".

"This discovery shows the role played by the gut microbiota in normal brain function," continues Gérard Eberl, Head of the Microenvironment and Immunity Unit (Institut Pasteur/Inserm) and joint last author of the study. If there is an imbalance in the gut bacterial community, some lipids that are vital for brain function disappear, encouraging the emergence of depressive-like behaviors. In this particular case, the use of specific bacteria could be a promising method for restoring a healthy microbiota and treating mood disorders more effectively.

Credit: 
Institut Pasteur

Faraday fabrics?

video: Drexel University researchers have developed a coating for materials that can block electromagnetic radiation. They demonstrate it's effectiveness by blocking a cell phone transmission by wrapping it in the material.

Image: 
Drexel University

Researchers at Drexel University's College of Engineering have reported that fabric coated with a conductive, two-dimensional material called MXene, is highly effective at blocking electromagnetic waves and potentially harmful radiation. The discovery is a key development for efforts to weave technological capabilities into clothing and accessories.

Materials that block electromagnetic waves had a commercial moment a handful of years ago when fears that high-tech thieves could scan or copy credit cards, passports or hack into laptops and contactless car keys had people putting them in special wallets, bags and protected pockets. While reporting suggests these fears were overblown, the demand for this sort of textile is likely to grow as more manufacturers incorporate sensing and communication technologies into fabrics.

They could also be deployed in national defense organizations to shield devices from tracing and hacking and to protect people from strong microwave radiation - the kind that might have been used against American and Canadian diplomats according to recent reports.

"Wearable devices will need shielding from the electromagnetic interference (EMI) regularly produced by mobile devices, and that shielding should be integrated as part of the garment," said Yury Gogotsi, PhD, Distinguished University and Bach professor at Drexel, who led research recently published in the materials science journal CARBON. "We have known for some time that MXene has the ability to block electromagnetic interference better than other materials, but this discovery shows that it can effectively adhere to fabrics and maintain its unique shielding capabilities."

The interference comes from residual electromagnetic fields produced by electronics devices. Users notice it as a buzz, a slowing or temporary stall in a device's function. It's a momentary inconvenience, but these moments are becoming more frequent with expanded use of mobile devices and connected technology - including wearables.

Improving the design of these devices, according to Gogotsi, entails using a shielding material to contain electromagnetic field generated by the device, as well as protecting it from interference produced by other devices. Gogotsi's team, which first produced and studied the conductive two-dimensional MXene materials nearly a decade ago, has been testing MXene coatings for this role, with promising results.

"MXenes are well-suited for use as shielding because they can be stably produced as a spray coating, an ink or a paint, so they can be applied to textiles without adding much weight or taking up more room," Gogotsi said. "We have also discovered that MXene shielding can absorb and reflect electromagnetic waves, so it not protects the wearable devices and electronic gadgets, but also protect people from strong electromagnetic field."

The researchers' most recent finding shows that dip-coating regular cotton or linen fabric in a MXene solution will turn it into an equally formidable shielding material - blocking EMI at greater than 99.9% effectiveness.

MXene flakes suspended in solution naturally adhere to the fibers in conventional cotton and linen fabrics because of their electric charge. This produces a thorough and durable coating, without the need for the pre- or post-treatment processes to produce most commercial conductive yarns and fabrics.

As part of the study, the MXene-coated fabrics were tested after being stored under normal conditions for two years and they showed only a slight drop in shielding efficiency - roughly 10%.

"This work provides a much-improved alternative to current EMI shielding textiles," said Simge Uzun, a doctoral student in Gogotsi's research group, who conducted this research as a part of her PhD program. "Not only do MXene-coated fabrics exceed the performance of commercial metal-coated fabrics, but they can be sustainably produced by coating form aqueous solution without extra processing or chemical additives."

Credit: 
Drexel University

tRNA fragments are involved in poststroke immune reactions

Sebastian Lobentanzer of Goethe University, Frankfurt, has been studying small RNA dynamics in various contexts using bioinformatic methods. Recently, small RNAs have become more and more interesting for researchers, primarily because of their extensive regulatory functions. To examine these functions in stroke, Lobentanzer joined Katarzyna Winek of Hebrew University, Jerusalem, to study microRNAs and tRNA fragments in blood samples from ischemic stroke patients collected at Charité, Berlin. "tRNA fragments, which until now were only thought to be debris of the amino acid-transporting tRNAs, have recently been shown to possess biological functions; naturally, we were very interested in that," explains the pharmacologist.

The project was initiated and led by Hermona Soreq (Hebrew University, Jerusalem, Israel) and Andreas Meisel (Charité, Berlin), who jointly study the contributions of small RNA regulators of cholinergic signaling in blood cells of stroke patients, funded by the Einstein Foundation. Katarzyna Winek from The Edmond and Lily Safra Center of Brain Science at The Hebrew University collaborated with Sebastian Lobentanzer at the Institute for Pharmacology and Clinical Pharmacy (AK Jochen Klein) at Goethe University Frankfurt, Germany.

This collaborative effort was able to show, for the first time, the involvement of monocytic tRNA fragments in the poststroke immune response. "Simply put, there may be a 'changing of the guards,' in which tRNA fragments replace microRNAs in monocytes," explains Lobentanzer. "Bioinformatic network analyses show that these two small RNA species have vastly different functional roles in the immune response, and thus may work in synergy in the regulation of homeostasis." In the long run, the researchers want to find therapeutics to modify these processes. Indeed, if the immune status of each patient after a stroke could be individually determined, many complications could be avoided.

Credit: 
Goethe University Frankfurt

Newly discovered toxin-antitoxin system abundant in one-cell organisms

image: A bacterial cell poisons itself with an antitoxin to prevent a virus from taking over, which is one important function of toxin-antitoxin systems discovered by Thomas Wood, Biotechnology Endowed Chair and professor of chemical engineering at Penn State.

Image: 
Ellie Jamison

Bacteria are always hungry, according to Thomas Wood, Biotechnology Endowed Chair and professor of chemical engineering in the Penn State College of Engineering. If you gave a single bacterium all the food it wanted, it would obtain the mass of the Earth in about two days.

To survive periods of starvation, bacteria must slow down their activity, or "go to sleep," according to Wood. Toxin-antitoxin (TA) systems, or small genetic elements found in the chromosomes of bacteria, allow bacteria to either speed up growth -- using antitoxins -- or slow down growth -- using toxins -- in order to thrive in periods where food is either plentiful or scarce.

Wood and his colleagues detail their discovery of a TA system that they named the HEPN/MNT system -- higher?eukaryotes and prokaryotes nucleotide-binding and minimal nucleotidyltransferase -- in Nucleic Acids Research.

"If you eat three meals a day, bacteria in your stomach starve between each of the meals," Wood said. "If bacteria did not have toxins to slow their metabolism and save their resources, they would run out of energy and die during each starvation period."

In the HEPN/MNT system, the MNT antitoxin "bites" the HEPN toxin to inactivate and block it. More specifically, adenosine triphosphate?(ATP) is transferred near the active site of the toxin protein, inhibiting the toxin.

"The easiest way for a bacterial cell to turn off a toxin is to bear-hug and hold on to it," Wood said. "We found in this specific system that the antitoxin acts as an enzyme to inactivate the toxin."

The HEPN/MNT system is the most abundant system found in prokaryotes, or one-cell organisms like bacteria, according to Wood.

Wood's latest discovery is the third type of TA system he has helped to discover and name. In 2008, with follow-up studies published in 2016, Wood discovered a new type of antitoxin that functions to oxidize?the toxin sulfur. Wood named the system "TomB" after Tom, his nickname.

In 2012, Wood published on a TA system known as GhoST, the first known TA system in which the antitoxin functions as an enzyme. In the system, the antitoxin GhoS consumes the genetic material, or mRNA, to remove the toxin, GhoT, from a bacterial cell. Otherwise, the toxin GhoT punches a hole in the cell membrane and puts the cell to sleep, giving it a ghost-like appearance.

"All antitoxins inactivate toxins and prevent them from slowing cell growth," Wood said. "The difference lies in how each antitoxin interacts with the?toxin."

TA systems are important both to conserve healthy bacteria and to fight off viruses.

"We have a love-hate relationship with bacteria, but we need them, especially in our digestive systems," he said.

Wood discovered in 1996 that TA systems slow down bacteria growth when a virus attacks in order to prevent the virus from killing the cell.

"TA systems prevent viruses from propagating to a hundred neighbors and taking control of a bacterial population," Wood said. "A virus has no way to kill a bacterium if it is asleep."

Credit: 
Penn State

Muscle cell secrets

image: In this single muscle fiber, a multitude of nuclei can be clearly seen. The researchers used DAPI for staining, it stains the DNA in the nuclei blue.

Image: 
C. Birchmeier Lab, MDC

A muscle fiber consists of just one cell, but many nuclei. A team at the MDC led by Professor Carmen Birchmeier has now shown just how varied these nuclei are. The study, which has been published in Nature Communications, can help us better understand muscle diseases such as Duchenne muscular dystrophy.

Usually, each cell has exactly one nucleus. But the cells of our skeletal muscles are different: These long, fibrous cells have a comparatively large cytoplasm that contains hundreds of nuclei. But up to now, we have known very little about the extent to which the nuclei of a single muscle fiber differ from each other in terms of their gene activity, and what effect this has on the function of the muscle.

A team led by Professor Carmen Birchmeier, head of the research group on Developmental Biology / Signal Transduction at the Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), has now unlocked some of the secrets contained in these muscle cell nuclei. As the researchers report in the journal Nature Communications, the team investigated the gene expression of cell nuclei using a still quite novel technique called single-nucleus RNA sequencing - and in the process, they came across an unexpectedly high variety of genetic activity.

Muscle fibers resemble entire tissues

"Due to the heterogeneity of its nuclei, a single muscle cell can act almost like a tissue, which consists of a variety of very different cell types," explains Dr. Minchul Kim, a postdoctoral researcher in Birchmeier's team and one of the two lead authors of the study. "This enables the cell to fulfill its numerous tasks, like communicating with neurons or producing certain muscle proteins."

Kim undertook the majority of the experimental work in the study, and his data was also evaluated at the MDC. The bioinformatics analyses were performed by Dr. Altuna Akalin, head of the Bioinformatics and Omics Data Science Platform at the MDC's Berlin Institute of Medical Systems Biology (BIMSB), and Dr. Vedran Franke, a postdoctoral fellow in Akalin's team and the study's co-lead author. "It was only thanks to the constant dialogue between the experiment-based and theory-based teams that we were we able to arrive at our results, which offer important insight for research into muscle diseases," emphasizes Birchmeier. "New techniques in molecular biology such as single cell sequencing create large amounts of data. It is essential that computational labs are part of the process early on as analysis is as important as data generation," adds Akalin.

Injured muscles contain activated growth-promoting genes

The researchers began by studying the gene expression of several thousand nuclei from ordinary muscle fibers of mice, as well as nuclei from muscle fibers that were regenerating after an injury. The team genetically labeled the nuclei and isolated them from the cells. "We wanted to find out whether a difference in gene activity could be observed between the resting and the growing muscle," says Birchmeier.

And they did indeed find such differences. For example, the researchers observed that the regenerating muscle contained more active genes responsible for triggering muscle growth. "What really astonished us, however, was the fact that, in both muscle fiber types, we found a huge variety of different types of nuclei, each with different patterns of gene activity," explains Birchmeier.

Stumbling across unknown nuclei types

Before the study, it was already known that different genes are active in nuclei located in the vicinity of a site of neuronal innervation than in the other nuclei. "However, we have now discovered many new types of specialized nuclei, all of which have very specific gene expression patterns," says Kim. Some of these nuclei are located in clusters close to other cells adjacent to the muscle fiber: for example, cells of the tendon or perimysium - a connective tissue sheath that surrounds a bundle of muscle fibers.

"Other specialized nuclei seem to control local metabolism or protein synthesis and are distributed throughout the muscle fiber," Kim explains. However, it is not yet clear what exactly the active genes in the nuclei do: "We have come across hundreds of genes in previously unknown small groups of nuclei in the muscle fiber that appear to be activated," reports Birchmeier.

Muscle dystrophy seemingly causes many nuclei types to be lost

In a next step, the team studied the muscle fiber nuclei of mice with Duchenne muscular dystrophy. This disease is the most common form of hereditary muscular dystrophy (muscle wasting) in humans. It is caused by a mutation on the X chromosome, which is why it mainly affects boys. Patients with this disease lack the protein dystrophin, which stabilizes the muscle fibers. This results in the cells gradually dying off.

"In this mouse model, we observed the loss of many types of cell nuclei in the muscle fibers," reports Birchmeier. Other types were no longer organized into clusters, as the team had previously observed, but scattered throughout the cell. "I couldn't believe this when I first saw it," she recounts. "I asked my team to repeat the single-nucleus sequencing immediately before we investigated the finding any further." But the results remained the same.

The mouse nuclei resemble those of human patients

"We also found some disease-specific nuclear subtypes," reports Birchmeier. Some of these are nuclei that only transcribe genes to a small extent and are in the process of dying off. Others are nuclei that contain genes that actively repair damaged myofibers. "Interestingly, we also observed this increase in gene activity in muscle biopsies of patients with muscle diseases provided by Professor Simone Spuler's Myology Lab at the MDC," says Birchmeier. "It seems this is how the muscle tries to counteract the disease-related damage."

"With our study, we are presenting a powerful method for investigating pathological mechanisms in the muscle and for testing the success of new therapeutic approaches," concludes Birchmeier. As muscular malfunction is also observed in a variety of other diseases, such as diabetes and age- or cancer-related muscle atrophy, the approach can be used to better research these changes too. "We are already planning further studies with other disease models," Kim confirms.

Credit: 
Max Delbrück Center for Molecular Medicine in the Helmholtz Association